Effect of hyoscine butylbromide (Buscopan®) on cholinergic pathways in the human intestine

Neurogastroenterology and Motility

Volumn 25, Issue 8, 2013, Pages

  Krueger, D ^a   Michel, K ^a   Allam, S ^a   Weiser, T ^b   Demir, I E ^a   Ceyhan, G O ^a   Zeller, F ^c   Schemann, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c Clinical Centre Freising   (Germany)

Author keywords

Enteric nervous system; Epithelial secretion; Hyoscine butylbromide; Muscarinic receptor; Smooth muscle motility

Indexed keywords

BETHANECHOL; SCOPOLAMINE BUTYL BROMIDE;

ARTICLE; CALCIUM MOBILIZATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IC 50; INTESTINAL SECRETION; INTESTINE; INTESTINE EPITHELIUM; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; NEUROIMAGING; PRIORITY JOURNAL;

ENTERIC NERVOUS SYSTEM; EPITHELIAL SECRETION; HYOSCINE BUTYLBROMIDE; MUSCARINIC RECEPTOR; SMOOTH MUSCLE MOTILITY;

BUTYLSCOPOLAMMONIUM BROMIDE; CHOLINERGIC NEURONS; ELECTRIC STIMULATION; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL MUCOSA; INTESTINES; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; ORGAN CULTURE TECHNIQUES;

EID: 84880134801     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12156     Document Type: Article

References (34)

1. Lecchini S, Del Tacca M, Soldani G, Frigg GM, Crema A. The actions of atropine, tropenziline and N-butyl hyoscine bromide on the isolated distal colon of the guinea-pig: a comparison of their activities and mechanisms of action. J Pharm Pharmacol 1969; 21: 662-7.
2. Mueller-Lissner S, Tytgat GN, Paulo LG et al. Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Aliment Pharmacol Ther 2006; 23: 1741-8.
3. Tytgat GN. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 2007; 67: 1343-57.
4. Ennes HS, McRoberts JA, Hyman PE, Snape WJ Jr. Characterization of colonic circular smooth muscle cells in culture. Am J Physiol 1992; 263: G365-70.
5. Purves RD. Muscarinic excitation: a microelectrophoretic study on cultured smooth muscle cells. Br J Pharmacol 1974; 52: 77-86.
6. Lyster DJ, Bywater RA, Taylor GS. Neurogenic control of myoelectric complexes in the mouse isolated colon. Gastroenterology 1995; 108: 1371-8.
7. Gomez A, Martos F, Bellido I et al. Muscarinic receptor subtypes in human and rat colon smooth muscle. Biochem Pharmacol 1992; 43: 2413-9.
8. Weiser T, Just S. Hyoscine butylbromide potently blocks human nicotinic acetylcholine receptors in SH-SY5Y cells. Neurosci Lett 2009; 450: 258-61.
9. Cellek S, John AK, Thangiah R et al. 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Neurogastroenterol Motil 2006; 18: 853-61.
10. Schicho R, Krueger D, Zeller F et al. Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology 2006; 131: 1542-52.
11. Krueger D, Gruber L, Buhner S et al. The multi-herbal drug STW 5 (Iberogast(R)) has prosecretory action in the human intestine. Neurogastroenterol Motil 2009; 21: 1203-e110.
12. Hohenester B, Ruhl A, Kelber O, Schemann M. The herbal preparation STW5 (lberogast) has potent and region-specific effects on gastric motility. Neurogastroenterol Motil 2004; 16: 765-73.
13. Michel K, Michaelis M, Mazzuoli G, Mueller K, Vanden Berghe P, Schemann M. Fast calcium and voltage-sensitive dye imaging in enteric neurones reveal calcium peaks associated with single action potential discharge. J Physiol 2011; 589: 5941-7.
14. Breunig E, Michel K, Zeller F, Seidl S, Weyhern CW, Schemann M. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol 2007; 583: 731-42.
15. Michel K, Zeller F, Langer R et al. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology 2005; 128: 1317-26.
16. Neunlist M, Peters S, Schemann M. Multisite optical recording of excitability in the enteric nervous system. Neurogastroenterol Motil 1999; 11: 393-402.
17. Kao WY, Davis CE, Kim YI, Beach JM. Fluorescence emission spectral shift measurements of membrane potential in single cells. Biophys J 2001; 81: 1163-70.
18. Krueger D, Zeller F, Langer R, Demir IE, Ceyhan GO, Schemann M. Functional characterisation of nerve mediated secretion in the human intestine in vitro. Gut 2010; 59 (Suppl. III): A53.
19. Schemann M, Michel K, Peters S, Bischoff SC, Neunlist M. Cutting-edge technology. III. Imaging and the gastrointestinal tract: mapping the human enteric nervous system. Am J Physiol Gastrointest Liver Physiol 2002; 282: G919-25.
20. Gray IR. Control of blood pressure. Br Med J 1972; 2: 31-3.
21. Harrington AM, Peck CJ, Liu L, Burcher E, Hutson JM, Southwell BR. Localization of muscarinic receptors M1R, M2R and M3R in the human colon. Neurogastroenterol Motil 2010; 22: 999-1008.
22. Tonini M, Costa M. A pharmacological analysis of the neuronal circuitry involved in distension-evoked enteric excitatory reflex. Neuroscience 1990; 38: 787-95.
23. Weber E, Neunlist M, Schemann M, Frieling T. Neural components of distension-evoked secretory responses in the guinea-pig distal colon. J Physiol 2001; 536: 741-51.
24. Khalif IL, Quigley EM, Makarchuk PA, Golovenko OV, Podmarenkova LF, Dzhanayev YA. Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics). J Gastrointest Liver Dis 2009; 18: 17-22.
25. Hirota CL, McKay DM. Cholinergic regulation of epithelial ion transport in the mammalian intestine. Br J Pharmacol 2006; 149: 463-79.
26. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 2000; 62: 535-72.
27. Hardcastle J, Hardcastle PT, Noble JM. The involvement of calcium in the intestinal response to secretagogues in the rat. J Physiol 1984; 355: 465-78.
28. Yang WL, Frucht H. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. Carcinogenesis 2000; 21: 1789-93.
29. Banks MR, Golder M, Farthing MJ, Burleigh DE. Intracellular potentiation between two-second messenger systems may contribute to cholera toxin induced intestinal secretion in humans. Gut 2004; 53: 50-7.
30. Pomeroy AR, Rand MJ. Anticholinergic effects and passage through the intestinal wall of N-butylhyoscine bromide. J Pharm Pharmacol 1969; 21: 180-7.
31. Sagrada A, Schiavone A, Cefala A, Trespi P, Giachetti A. N-butyl hyoscine exerts local spasmolytic effect in the small and large bowel of the conscious dog. Arch Int Pharmacodyn Ther 1987; 287: 237-47.
32. Kerr PM, Hillier K, Wallis RM, Garland CJ. Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon. Br J Pharmacol 1995; 115: 1518-24.
33. Law NM, Bharucha AE, Undale AS, Zinsmeister AR. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1228-37.
34. Lefebvre RA, Ferrero S, Van C et al. Influence of 5-HT4 receptor activation on acetylcholine release in human large intestine with endometriosis. Neurogastroenterol Motil 2010; 22: 557-63.